top of page
webisite (12 × 4.25 in).png

Partners

Who are we?

Lung Cancer Canada is a registered national charity that serves as Canada’s leading resource for lung cancer education, patient support, research and advocacy.

​

Lung Cancer Canada’s mission aims to:

  • To increase public awareness of lung cancer

  • To support and advocate for lung cancer patients and their families

  • To provide educational resources to patients, family members, healthcare professionals, and the

    general public

  • Support promising research opportunities in lung cancer

The Lung Ambition Alliance is a partnership of patient organizations, scientific and medical societies,

and industry committed to tackling barriers to ultimately eliminate lung cancer as a cause of death.

The Lung Ambition Alliance aims to double 5-Year Survival in Lung Cancer.

​

Goal: Support initiatives that are aligned to the Lung Ambition strategy and will have meaningful impact on patient outcomes:

  • Screen & diagnose early

  • Enhance the quality of care

  • Improve patient outcomes

 

Lung Cancer Canada is a registered national charity that serves as Canada’s leading resource for lung cancer education, patient support, research and advocacy.

​

  • Lung Cancer Canada’s mission aims to:

  • To increase public awareness of lung cancer

  • To support and advocate for lung cancer patients and their families

  • To provide educational resources to patients, family members, healthcare professionals, and the

    general public

  • Support promising research opportunities in lung cancer

image (2).png
Screen Shot 2022-11-28 at 1.58.13 PM.png

About the partners

 

  • Lung Cancer Canada is a registered national charity that serves as Canada’s leading resource for lung cancer education, patient support, research and advocacy. Based in Toronto, Ontario, Lung Cancer Canada has a wide reach that includes both regional and pan-Canadian initiatives. Lung Cancer Canada is a member of the Global Lung Cancer Coalition and is the only national organization in Canada focused exclusively on lung cancer.

 

  • AstraZeneca is a global, innovation-driven biopharmaceutical business with a focus on the discovery, development, and commercialization of medicines that transform lives. AstraZeneca’s core areas of scientific focus are Cardiovascular, Renal and Metabolic (CVRM) disease; Oncology; Rare Disease; Respiratory & Immunology; and Vaccine & Immune Therapies.

 

  • The Lung Ambition Alliance is a global coalition, with cross-discipline partners in more than 50 countries dedicated to accelerating innovation and driving meaningful improvements for people with lung cancer. With the bold ambition to one day eliminate cancer as a cause of death, the Alliance is focused on three core areas: increasing screening & diagnosis; delivering innovative medicine; and enhancing the quality of care for lung cancer patients.

bottom of page